Hong-ying Guo
Shanghai, 200030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Multi-Omics profiling identifies aldehyde dehydrogenase 2 as a critical mediator in the crosstalk between Treg-mediated immunosuppression microenvironment and hepatocellular carcinoma.
Journal: International journal of biological sciences
Published: December 09, 2023
ASO Author Reflections: mLST8 is a Prognostic Biomarker and Involved in Tumor Progression in Hepatocellular Carcinoma.
Journal: Annals of surgical oncology
Published: February 06, 2020
Enhanced mLST8 Expression Correlates with Tumor Progression in Hepatocellular Carcinoma.
Journal: Annals of surgical oncology
Published: September 20, 2019
Upregulated calcium-binding tyrosine phosphorylation-regulated protein-a/b regulates cell proliferation and apoptosis and predicts poor prognosis in hepatocellular carcinoma.
Journal: Journal of cellular biochemistry
Published: July 20, 2019
Comprehensive analysis of long non‑coding RNA‑messenger RNA‑microRNA co‑expression network identifies cell cycle‑related lncRNA in hepatocellular carcinoma.
Journal: International journal of molecular medicine
Published: April 11, 2019
UBE2T promotes proliferation via G2/M checkpoint in hepatocellular carcinoma.
Journal: Cancer management and research
Published: January 23, 2019
Overexpressed pepsinogen C is associated with poor prognosis in human hepatocellular carcinoma: a tissue microarray study.
Journal: Cancer management and research
Published: October 25, 2018
Microarray Expression Profiling of microRNAs Reveals Potential Biomarkers for Hepatocellular Carcinoma.
Journal: The Tohoku journal of experimental medicine
Published: June 15, 2018
microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 08, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026